Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CyMedica Orthopedics develops FDA-cleared, app-based neuromuscular electrical stimulation devices designed to strengthen muscles—primarily the quadriceps—in patients with knee osteoarthritis or recovering from knee surgery. Their flagship product, e-vive™ (now also marketed as Motive Knee), enables individualized at-home therapy while transmitting real-time progress data to healthcare providers. Clinical studies have shown that use of their NMES systems can accelerate rehabilitation and improve functional outcomes after knee replacement surgeries by reducing muscle atrophy and supporting joint function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CyMedica Orthopedics.